Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update

By Ayoola Ayodele   Barochia Amit   Belani Kiran   Belani Chandra P.  

Cancer Investigation, Vol. 30, Iss. 5, 2012-05 ,pp. : 433-446

Informa Healthcare

Access to resources Recommend Favorite

A Comparison of Epidermal Growth Factor Receptor Levels and Other Prognostic Parameters in Non-small Cell Lung Cancer

By Fujino S.   Enokibori T.   Tezuka N.   Asada Y.   Inoue S.   Kato H.   Mori A.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2070-2074

Elsevier

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFr) Expression in Non-small Cell Lung Carcinomas Correlates with Metastatic Involvement of Hilar and Mediastinal Lymph Nodes in the Squamous Subtype

By Fontanini G.   Vignati S.   Bigini D.   Mussi A.   Lucchi H.   Angeletti C.A.   Pingitore R.   Pepe S.   Basolo F.   Bevilacqua G.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 178-183

Elsevier

Access to resources Recommend Favorite

Patterns of epidermal growth factor receptor mutation in non-small-cell lung cancers in the Gulf region

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1371-1374

Science Publishers

Access to resources Recommend Favorite

Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers

By Huang Cheng-long   Yokomise Hiroyasu   Miyatake Akira  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 83-93

Future Medicine

Access to resources Recommend Favorite